FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump says ‘America needs God’ in Good Friday message touting ‘resurgence of religion’

Watch: DEI-Obsessed Sky News Reporter Claims Moon Landings by ‘All White Men’ Didn’t Represent Humanity

Pro-Lifers Shred Trump Admin’s Biden-Era Title X Extension as ‘Inexplicable Slap in the Face’

Trump Admin Declares War on Microplastics in Drinking Water

Trump Executive Order Aims to Save College Sports, Limit Athlete Transfers

They’re Teaching This to Kids: California Schools Can’t Tell Difference Between Jan 6 And KKK

Artemis II astronauts nearly halfway to the moon; NASA shares stunning photos from Orion spacecraft

‘It’s Insane’: Obama’s Former Chief of Staff Admits Dems ‘Lost the Plot’

California 4-year-old boy survives attack by coyote that bit and tried to drag him away

Trump requests over $10 billion for DC infrastructure and National Guard deployment

Coast Guard captured on camera rescuing federal agents, boaters after 2 vessels capsize off Puerto Rico

Colorado lawyers say court e-file system now makes them certify they won’t assist ICE

Patel, McCormick warn foreign terror threats inside US grew during Biden years

Trump gives rare praise to persistent GOP foe after White House ballroom vote

Florida man charged with murder after allegedly stabbing woman to death in random attack in quiet neighborhood

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”